Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. - Wikidata - awgldk - TriplyDB

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

http://www.wikidata.org/entity/Q44290885

about

A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD Cognitive enhancers for the treatment of ADHD Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder Norepinephrine transporter inhibitors and their therapeutic potential Adult ADHD: Diagnosis, Differential Diagnosis, and Medication Management The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication A randomized, double-blind, placebo-controlled phase 2 study of α4β2 agonist ABT-894 in adults with ADHD Using Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit/Hyperactivity Disorder in Youths Treatment of adults with attention-deficit/hyperactivity disorder Treatment of adults with attention-deficit/hyperactivity disorder Comparing the efficacy of medications for ADHD using meta-analysis Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder: a drug-placebo response curve analysis.A critical appraisal of atomoxetine in the management of ADHD Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults Pharmacological treatment of adult ADHD in Europe Bupropion for adults with attention-deficit hyperactivity disorder: meta-analysis of randomized, placebo-controlled trials A pilot open label prospective study of memantine monotherapy in adults with ADHD Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients Do adrenergically active drugs have a role in the first-line treatment of attention-deficit/hyperactivity disorder?Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management A retrospective claims analysis of combination therapy in the treatment of adult attention-deficit/hyperactivity disorder (ADHD)Serotonin enhances the impact of health information on food choice Classification of Therapeutic and Experimental Drugs for Brown Adipose Tissue Activation: Potential Treatment Strategies for Diabetes and Obesity Atomoxetine changes rat's HR response to stress from tachycardia to bradycardia via alterations in autonomic function.Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication.Atomoxetine effects on executive function as measured by the BRIEF--a in young adults with ADHD: a randomized, double-blind, placebo-controlled study.Efficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial.Cognitive enhancers in the treatment of substance use disorders: clinical evidence.An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder Meta-analysis of suicide-related behavior or ideation in child, adolescent, and adult patients treated with atomoxetine.Methylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial.Treatment of attention deficit hyperactivity disorder in adults.Attention benefits after a single dose of metadoxine extended release in adults with predominantly inattentive ADHD.A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: an integrated analysis of the complete database of multicenter placebo-controlled trials.Off-label use of atomoxetine in adults: is it safe?The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative.

P2860

Q21093202-B2B93A02-AFEE-4DA0-9B35-FA26CC7C6A32 Q22251235-C25A1B9F-B380-4440-A2C8-99C4C42CD02F Q22252504-339B2BFA-F169-4CDA-A1C9-29F89929AC2B Q24554381-3D69E7D5-72F6-4D28-8655-D3F9023C2B3E Q24630109-EE8EA198-DBDF-47E3-B3E3-AA5B77040D8F Q24632666-80FE54E5-0E11-4670-B61D-0D64E6406416 Q24632726-F680A197-2A8D-4BE1-891D-59CB92304E45 Q24642024-4AE6CB85-9798-4CB2-B2F5-D4102930D20B Q24642937-417ADE33-2BA4-4643-94F3-EBC2F4B8C0EF Q24644586-303B1274-8AEE-4EE5-85D7-A1BB9DC23A2C Q24685027-87290FDC-2334-4177-93E2-69ECB0FE016D Q24814791-064DCBF7-3908-4F78-B304-B650BB24AE53 Q26771187-378B8DA7-9FBB-451C-B6F9-E46FB49E5C40 Q28243031-CE012BA1-0C4E-4C2D-9B7A-249311AC91D9 Q28246506-CB91792C-81C9-4C8E-9E98-D502C48D1A7F Q28247634-7EDB7353-CDCD-4C65-B68A-6E7072E5830F Q28255609-5F784EF9-9169-4031-B50F-17AEDCF193A8 Q28262447-C70BFA3C-73FD-4495-B009-DABA2378EB6D Q28267079-C465A2BF-012E-48A5-975A-8A36A550521D Q28274915-ACD4D9F2-5671-420A-954A-A9EF0624C234 Q28279863-2AFEAC7D-AD70-4168-9B76-FA3F58E3A9B8 Q28295525-1803011F-EDFA-41EA-9E5A-ABFC56F174CC Q33463879-62A90DE7-4310-4F0A-8904-A225EE51C998 Q33600039-4E41F35D-500C-4177-86AC-F675FC3E19CD Q33659194-225941EC-79B3-4580-BAAD-A3B027F9E99E Q33751047-656F3C15-58CD-4E78-8A19-8F907D82791C Q33760743-4164724B-8B60-4157-97C6-826763BBA661 Q34078532-4FD0AC6B-E89E-4BAC-8B86-3ECC783F9B46 Q34163924-C0453336-A481-4264-A421-1B81F959D5CD Q34183988-6189EB03-4348-4C83-8020-4634BEA7473B Q34220004-6200131E-2D09-4DBB-9F01-336C431383AA Q34221423-6F42BAD0-6DB1-46AA-A796-A12CE95D272D Q34370417-CFD8DCA7-29AD-4AA1-92F3-50039D27FCD6 Q34394522-048A1C27-6AF3-4724-AF29-AEAF403017E7 Q34413877-F375FCFD-9F42-4464-BCD0-07AF24A7AE78 Q34442413-50CFFC72-8D89-4D97-8928-6C4E8E23E713 Q34481402-2B621739-CB1A-426F-A8FD-AC7972AEB6B3 Q34505285-2ADDD6FF-0E5A-4144-8F65-3A9531A855E9 Q34618993-A0CEE83E-1E96-4475-A4E6-0330AF093152 Q34781993-EA22FB1F-D501-4040-9268-CE70A5C5E61A

P2860

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

http://www.wikidata.org/entity/Q44290885

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

@en

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

@nl

type

label

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

@en

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

@nl

prefLabel

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

@en

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

@nl

P1433

Q44290885-EF61D432-D512-46F6-B620-F12730A2AB52

P1476

Q44290885-CBCAE586-4736-4843-9213-D4F4999DAB54

P2093

Q44290885-1AB49B23-D9AB-4CDB-B264-CF3E5ED9EE20

Q44290885-2769AE06-E90A-48B1-A144-6414643BC21C

Q44290885-390EF615-B9C4-4410-8507-D42E15524B78

Q44290885-3C7A3BB6-4916-4EAD-B9EB-9693AF162D26

Q44290885-47271062-6B14-4E5C-A55F-D08F42932EE7

Q44290885-AEA4AB8C-ED76-4DC2-AD3E-906EF5F89195

Q44290885-D2A8F524-5200-4D08-8307-CB2406BED2C1

Q44290885-E3AE7504-2D58-47FC-875D-EAE2D22C6713

Q44290885-F86B1F73-29EA-45BB-A187-BD4787103E45

Q44290885-FA11F454-21A0-4BB9-9F15-386EC57BFC2E

P304

Q44290885-7092E3BC-EF04-49C8-BB6D-9D81224AE1FB

P31

Q44290885-F4E64A0D-C4DB-4213-9CE2-04EF2BFE3F3F

P356

Q44290885-7F6F8496-9F51-4F36-A3FB-31C493E262E5

P407

Q44290885-BBA35BF9-5D3E-444A-B65C-74281F22E7A5

P433

Q44290885-40997758-6B7F-40F3-82E2-E85D39B21ABA

P478

Q44290885-3251D6F2-75DF-481E-B0E8-C3B7D67930AF

P577

Q44290885-BAFC1085-4160-4DE2-8A38-F0378EB232DE

P5875

Q44290885-EF76A9B6-8436-4E81-8014-DF92E975705F

P698

Q44290885-79B26100-4FC0-49B4-850A-347A4B7533FB

P921

Q44290885-DA0C7FF6-0504-4851-8D6B-42CA7951E278

P356

S0006-3223(02)01671-2

P1433

Biological Psychiatry

P1476

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

@en

P2093

Albert J Allen

http://www.w3.org/2001/XMLSchema#string

Anthony Dietrich

http://www.w3.org/2001/XMLSchema#string

David Michelson

http://www.w3.org/2001/XMLSchema#string

Denái Milton

http://www.w3.org/2001/XMLSchema#string

Douglas Kelsey

http://www.w3.org/2001/XMLSchema#string

Frederick W Reimherr

http://www.w3.org/2001/XMLSchema#string

Joachim Wernicke

http://www.w3.org/2001/XMLSchema#string

Lenard Adler

http://www.w3.org/2001/XMLSchema#string

Scott A West

http://www.w3.org/2001/XMLSchema#string

Thomas Spencer

http://www.w3.org/2001/XMLSchema#string

P304

112-120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0006-3223(02)01671-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10934464

http://www.w3.org/2001/XMLSchema#string

P698

12547466

http://www.w3.org/2001/XMLSchema#string

P921